It's important they have a voice in this process. Researchers hope to develop an educational tool that helps women make informed choices about tamoxifen. Based on National Cancer Institute estimates, approximately 25 million women in the United States are potentially eligible to take the drug for breast cancer prevention. Interviews in Spanish and English are being held at UC Davis Medical Center and will be scheduled at local community centers on weekdays and weekends. Most have never participated in a study or know how the process works.
Language can be a barrier, as can getting transportation to a study site.
And they're understandably concerned about just what we're going to be doing with this information. We want to assuage these concerns. In addition to being over 50, potential participants must also meet a risk profile that is determined by completing a short questionnaire. The questionnaire can be answered by phone. The California Breast Cancer Prevention program is funding the two-year study.